Genetic Characteristics of HER2 Positive Breast Cancer With Neoadjuvant TCHP Chemotherapy

NCT04276337 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Chemotherapy Effect
Circulating Tumor DNA

Interventions

DIAGNOSTIC_TEST: LiquidSCAN(Trade Mark) / CancerSCAN(Trade Mark)

Sponsor

Samsung Medical Center